Psychedelic risks and benefits: A cross-sectional survey study.
Journal of psychopharmacology (Oxford, England) May 1, 2025 Sean P. Goldy, Benjamin A Du, Julia S Rohde et al. 15 citations
As classic psychedelics' therapeutic potential is studied and their popularity continues to rise, it is important to establish their relative risks and benefits. Previous surveys have tended to use convenience sampling on social media, select participants who have had either extremely positive or negative effects, and have not compared the risk/benefit profile of psychedelics to other...